Kentucky Dangerous Drug Attorney: American Academy of Ophthalmology Concerned About Latisse
Latisse (marketed as Lumigan) by manufacturer Allergan, is a drug that originally was prescribed for glaucoma. However, it was approved last year for cosmetic purposes, specifically for eyelash enhancement.
Although it has been a big hit with women seeking to enhance their eyelashes, ophthalmologists are concerned about the side effects including redness, itchiness, irritation, bacterial infection, unintended and excess hair growth outside the treatment area and darkening of the skin around the application area. Latisse potentially could also cause a change in eye color, especially in people who have any amount of brown pigment in their eyes.
The FDA sent a warning letter to Allergran in September criticizing the Latisse website
Frequently Asked Questions and About Safety section for minimizing or failing to mention the potential problems.
For more information on this subject and the rights of those injured or killed by dangerous and defective products and drugs, contact Louisville, Kentucky attorney Will Nefzger by clicking on this link: e-mail Will. You can also find out more information about me and my firm by clicking on the Website link at the top of this page and going to my bio page.
